FY2024 EPS Estimate for Prime Medicine Decreased by Analyst
Prime Medicine, Inc. (NYSE:PRME – Free Report) – Equities research analysts at HC Wainwright reduced their FY2024 earnings estimates for Prime Medicine in a research note issued on Wednesday, November 13th. HC Wainwright analyst A. He now expects that the company will earn ($1.69) per share for the year, down from their previous estimate of […]
15 Nov 11:54 · The Markets Daily